Amit Patel is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the fields of medicine and biotechnology, particularly in the treatment of diabetes and heart failure. With a total of two patents to his name, Patel's work focuses on innovative methods to enhance immune cell functionality for therapeutic purposes.

Latest Patents

Amit Patel's latest patents include groundbreaking inventions aimed at addressing critical health issues. The first patent is titled "Prevention and/or treatment of type 1 diabetes by augmentation of myeloid suppressor cell activity." This invention discloses methods and compositions that facilitate the prevention and reversion of type 1 diabetes by upregulating myeloid suppressor cell activity in mammals. The patent emphasizes the administration of immune cells conditioned by regenerative cells, particularly umbilical cord-derived mesenchymal stem cells, to enhance therapeutic outcomes.

The second patent, "Treatment of heart failure and/or post infarct pathological remodeling by ex vivo reprogrammed immune cells," outlines methods for treating heart failure and post-infarct remodeling using reprogrammed immune cells. This invention describes the coculturing of autologous recipient cells with regenerative cell populations, which enhances the transfer of regenerative activity and provides antifibrotic effects to promote cardiac regeneration.

Career Highlights

Throughout his career, Amit Patel has worked with various organizations, including Creative Medical Technologies, Inc. and his own venture, Patel, Amit. His innovative approaches and dedication to advancing medical science have positioned him as a key figure in his field.

Collaborations

Amit Patel has collaborated with notable professionals, including Thomas E Ichim, to further his research and development efforts. These collaborations have contributed to the advancement of his patented technologies and their potential applications in clinical settings.

Conclusion

Amit Patel's contributions to medical innovation through his patents reflect his commitment to improving health outcomes for patients. His work in enhancing immune cell functionality for the treatment of diabetes and heart failure showcases the potential of biotechnology in addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.